Placement Pending

Sensei Biotherapeutics placement

US$200m raised

Announced 18 Feb 2026 · NASDAQ: SNSE · US$13850.00 cash per share

Advisers

Issuer
Sensei Biotherapeutics
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.